- Home
- DB vs RMD Comparison
DB vs RMD Comparison
Compare DB & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DB
- RMD
- Stock Information
- Founded
- DB 1870
- RMD 1989
- Country
- DB Germany
- RMD United States
- Employees
- DB N/A
- RMD N/A
- Industry
- DB Major Banks
- RMD Medical/Dental Instruments
- Sector
- DB Finance
- RMD Health Care
- Exchange
- DB Nasdaq
- RMD Nasdaq
- Market Cap
- DB 33.6B
- RMD 36.5B
- IPO Year
- DB N/A
- RMD 1995
- Fundamental
- Price
- DB $16.97
- RMD $234.84
- Analyst Decision
- DB Buy
- RMD Buy
- Analyst Count
- DB 2
- RMD 11
- Target Price
- DB N/A
- RMD $227.63
- AVG Volume (30 Days)
- DB 1.9M
- RMD 1.2M
- Earning Date
- DB 10-23-2024
- RMD 10-24-2024
- Dividend Yield
- DB 2.88%
- RMD 0.90%
- EPS Growth
- DB N/A
- RMD 22.60
- EPS
- DB 2.11
- RMD 7.54
- Revenue
- DB $30,817,532,890.00
- RMD $4,807,485,000.00
- Revenue This Year
- DB N/A
- RMD $10.09
- Revenue Next Year
- DB $3.26
- RMD $7.15
- P/E Ratio
- DB $7.60
- RMD $31.13
- Revenue Growth
- DB 1.70
- RMD 9.88
- 52 Week Low
- DB $12.05
- RMD $147.39
- 52 Week High
- DB $17.95
- RMD $260.49
- Technical
- Relative Strength Index (RSI)
- DB 49.40
- RMD 41.83
- Support Level
- DB $16.30
- RMD $231.18
- Resistance Level
- DB $17.21
- RMD $255.16
- Average True Range (ATR)
- DB 0.24
- RMD 5.65
- MACD
- DB -0.05
- RMD -1.55
- Stochastic Oscillator
- DB 56.78
- RMD 15.26
About DB Deutsche Bank AG
Deutsche Bank is a universal bank operating on a global scale. The bank offers corporate, retail, investment banking, private banking, and asset management to its clients.
About RMD ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.